by admin | Jan 29, 2022 | Insights
An exciting psychedelics update from the land down under: The Medical Research Future Fund (MRFF), under the Australian Government’s Innovative Therapies for Mental Illness Grant, has awarded two Sydney research teams a total of over A$3 million ($2.24 million)...
by admin | Jan 17, 2022 | Insights
#ICYMI: An interview in Psychology Today with Kelley O’Donnell, a psychiatrist and researcher who provides psychedelic-assisted psychotherapy in controlled clinical settings at NYU Langone Health’s Center for Psychedelic...
by admin | Jan 17, 2022 | Insights
“Follow the data and (don’t) get ahead of it, but at the same time, recognize it is an exciting development,” says Dr. Matthew W. Johnson, a professor of psychiatry and behavioural sciences at The Johns Hopkins University School of Medicine.A...
by admin | Jan 17, 2022 | Insights
A fantastic primer via Psychedelic Spotlight on the January 5 regulatory changes to Health Canada’s Special Access Program, and what it means for the future of psychedelic-assisted therapy in...
by admin | Jan 17, 2022 | Insights
Big news out of Canada this week: Health Canada, the country’s Federal health policy regulator, has given the green light for psychedelic drugs such as MDMA and magic mushrooms to be used for medical purposes. Health care advocates are calling it a major...
Recent Comments